Loading...
Teriflunomide Does Not Change Dynamics of Nadph Oxidase Activation and Neuronal Dysfunction During Neuroinflammation
The multiple sclerosis therapeutic teriflunomide is known to block the de novo synthesis of pyrimidine in mitochondria by inhibiting the enzyme dihydroorotate-dehydrogenase (DHODH). The metabolic processes of oxidative phosphorylation and glycolysis are further possible downstream targets. In health...
Na minha lista:
| Udgivet i: | Front Mol Biosci |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7203781/ https://ncbi.nlm.nih.gov/pubmed/32426367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.00062 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|